Abstract |
Ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin- 7-ylcarbamate, 2-hydroxyethanesulfonate, hydrate ( NSC 370147) was evaluated for antitumor activity against a spectrum of tumor systems in culture and in mice. NSC 370147 was cytotoxic to a variety of mouse and human cell lines at nanomolar concentrations. The compound exhibited good in vivo antitumor activity against several murine tumors (P388 and L1210 leukemia, colon 11/A and 36, mammary 16/C, and M5076 sarcoma). Activity was largely independent of route of administration but favored a prolonged treatment schedule. NSC 370147 was as active against murine leukemia sublines resistant to Adriamycin, amsacrine, vincristine, melphalan, cisplatin, methotrexate, and CI-920 (a topoisomerase II inhibitor) as against the corresponding parental lines. Only the 1-beta-D-arabinofuranosylcytosine-resistant P388 subline exhibited any cross-resistance to NSC 370147. NSC 370147 has a spectrum of activity similar to that of vincristine and, unlike vincristine, is active against multidrug-resistant cell lines. Therefore, NSC 370147 is a candidate for clinical trial because of its favorable activity compared to vincristine, its effectiveness against multidrug-resistant cells, and its retention of activity for p.o. administration.
|
Authors | W R Waud, W R Leopold, W L Elliott, D J Dykes, W R Laster Jr, C G Temple Jr, S D Harrison Jr, D P Griswold Jr |
Journal | Cancer research
(Cancer Res)
Vol. 50
Issue 11
Pg. 3239-44
(Jun 01 1990)
ISSN: 0008-5472 [Print] United States |
PMID | 2334919
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antineoplastic Agents
- Pyrazines
- NSC 350386
|
Topics |
- Animals
- Antineoplastic Agents
(therapeutic use)
- Drug Administration Schedule
- Drug Resistance
- Drug Screening Assays, Antitumor
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Inbred DBA
- Neoplasms
(drug therapy)
- Pyrazines
(administration & dosage, pharmacology)
- Tumor Cells, Cultured
(drug effects)
|